Immunology, Inflammation, & Infectious Disease (3i) Initiative

A microbe called Turicibacter improves metabolic health and reduces weight gain in mice. The results could lead to new ways to control weight by adjusting gut bacteria.

University of Utah Health Research Office is the engine that powers health sciences research. We provide essential core services, reimagine research education, secure philanthropic support, and everything in between.

Drugs currently in clinical trials for other conditions could help reduce risk of heart attack and stroke for IBD patients. "This could be lifesaving," senior author says.

Disease modeling research suggests that for some cholera outbreaks, prescribing antibiotics more aggressively could slow or stop the spread of the disease and even reduce the likelihood of antibiotic resistance.

Leading scientists joined forces to explore how the microbes that live in and on our bodies can be leveraged to provide real-world solutions and improve health care.

Research has found that C. difficile, one of the most contagious hospital-acquired infections, spreads more than three times more than previously thought, moving covertly from surface to surface.